Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T52450 | Target Info | |||
Target Name | Matrix metalloproteinase-1 (MMP-1) | ||||
Synonyms | Interstitial collagenase; Fibroblast collagenase; CLG | ||||
Target Type | Successful Target | ||||
Gene Name | MMP1 | ||||
Biochemical Class | Peptidase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | MMI270 | Ligand Info | |||
Canonical SMILES | CC(C)C(C(=O)NO)N(CC1=CN=CC=C1)S(=O)(=O)C2=CC=C(C=C2)OC | ||||
InChI | 1S/C18H23N3O5S/c1-13(2)17(18(22)20-23)21(12-14-5-4-10-19-11-14)27(24,25)16-8-6-15(26-3)7-9-16/h4-11,13,17,23H,12H2,1-3H3,(H,20,22)/t17-/m1/s1 | ||||
InChIKey | BSIZUMJRKYHEBR-QGZVFWFLSA-N | ||||
PubChem Compound ID | 446504 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 3AYK CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, MINIMIZED AVERAGE STRUCTURE | ||||||
Method | Solution NMR | Resolution | N.A. | Mutation | No | [1] |
PDB Sequence |
PRWEQTHLTY
16 RIENYTPDLP26 RADVDHAIEK36 AFQLWSNVTP46 LTFTKVSEGQ56 ADIMISFVRG 66 DHRDNSPFDG76 PGGNLAHAFQ86 PGPGIGGDAH96 FDEDERWTNN106 FREYNLHRVA 116 AHELGHSLGL126 SHSTDIGALM136 YPSYTFSGDV146 QLAQDDIDGI156 QAIYGRS |
|||||
|
||||||
PDB ID: 4AYK CATALYTIC FRAGMENT OF HUMAN FIBROBLAST COLLAGENASE COMPLEXED WITH CGS-27023A, NMR, 30 STRUCTURES | ||||||
Method | Solution NMR | Resolution | N.A. | Mutation | No | [1] |
PDB Sequence |
VLTEGNPRWE
10 QTHLTYRIEN20 YTPDLPRADV30 DHAIEKAFQL40 WSNVTPLTFT50 KVSEGQADIM 60 ISFVRGDHRD70 NSPFDGPGGN80 LAHAFQPGPG90 IGGDAHFDED100 ERWTNNFREY 110 NLHRVAAHEL120 GHSLGLSHST130 DIGALMYPSY140 TFSGDVQLAQ150 DDIDGIQAIY 160 GRSQNPVQP
|
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound. Biochemistry. 1999 Jun 1;38(22):7085-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.